BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2003

View Archived Issues

Medtronic initiates Talent(TM) Thoracic Stent Graft Study in the US

Read More

Caspase-3 inhibition preserves myocardial geometry and long-term function postinfarction in mice

Read More

Neramexane shows promise for the treatment of alcohol dependence

Read More

Antalarmin reduces volitional ethanol consumption in rats

Read More

Hyperforin, an antidepressant with a novel mechanism of action

Read More

Pharmacological profiles of novel dual D2/5-HT1A-acting antipsychotics

Read More

Antidepressant/anxiolytic effects of CP-154526 shown in a rat model of depression

Read More

Proton pump inhibitors and cytochrome P-450 polymorphism in GERD

Read More

Therapeutic benefits of rabeprazole in ulcers and GERD

Read More

BIA-2-024 and BIA-2-093 reported less neurotoxic than current antiepileptics

Read More

Fast and potent analgesic effects of AZD-3582 in a rat model of monoarthritis

Read More

First evidence of antiinflammatory effects induced by cilomilast in COPD patients

Read More

New thyroid receptor antagonists and their use described in Karo Bio patent

Read More

Solvay scientists describe novel NK1 antagonists for pain, emesis, arthritis, etc.

Read More

Novartis claims MMP inhibitors with utility in neuropathic pain therapy

Read More

Gruenenthal patent covers new NBTI analogues with potential as analgesic agents

Read More

New NR2B NMDA antagonists in early development at Merck

Read More

Novel factor Xa inhibitors prepared and tested at Merck KGaA

Read More

New M3 antagonists/PDE4 inhibitors for COPD and other uses claimed by UCB team

Read More

Pliva presents azulene-based inhibitors of TNF-alpha and/or IL-1 production

Read More

Two phase III studies for Retaane planned for January

Read More

BTG seeks development partners for PDE-4 inhibitor portfolio

Read More

Encouraging results for Crucell's experimental malaria vaccine

Read More

Dendreon grants Kirin HLA-DR antibody license, regains Asian Provenge rights

Read More

Swiss prenotification of intent to approve Erbitux

Read More

Nobex to reacquire modified insulin molecule rights from GlaxoSmithKline

Read More

Arthron compounds produce sustained suppression of rheumatoid arthitis

Read More

Sinovac new name for Net Force Systems

Read More

Subcutaneous CERA increases plasma hemoglobin in patients with chronic renal anemia

Read More

Good safety profile found for pyridoxamine in patients with diabetic nephropathy

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing